Will Biotechs Follow Manic Depression Tradition and Outperform Market
in 1997's Second Half? Experts to Discuss Biotech Prospects on Aug. 9
====================================================
SAN DIEGO--(BW HealthWire)--Aug. 7, 1997--Will biotechnology
stocks follow tradition, snap out of their recent slump and
outperform the broader market over the balance of 1997? And which
biotech companies are likely to be the winners/losers in the coming
years?
Those topics and more will be probed at the 1st Annual San Diego
Biotechnology Forum Saturday morning Aug. 9 at the Mission Valley
DoubleTree. The Forum is produced by Sacramento-based Informed
Investors Forum and co-sponsored by Investor's Business Daily.
Designed for individual investors, the Forum includes full
analyst-style presentations by the chief executives at four leading
San Diego biotech companies plus the featured address by James
McCamant, Editor of the Medical Technology Stock Letter and a leading
biotech authority.
The Forum runs from 8:30 a.m. to 12:30 p.m. The cost is $15
pre-paid and $20 at the door. Included is a continental breakfast
served at 8 a.m. Investors unable to attend may order tapes of the
Forum for $25, which includes shipping/handling and postage. Call
800/992-4683.
Biotech stocks often go against broader market cycles. According
to prominent biotech analyst David Crossen of Montgomery Securities,
"...Biotech stocks have a 10-year record of manic depression...
out performance half the year, under performance the other half."
In early 1997, biotech stocks were ranked near the top of nearly
200 industry groups rated by Investors' Business Daily. Currently,
biotechs are near the bottom.
McCamant will put current biotech stock prices in historical
perspective and explain the role of clinical trials, strong
management and market timing in biotech investing. McCamant will
also address the importance of corporate partnerships, competition
and proprietary science in valuing biotech stocks.
In addition, attendees will hear about cutting edge research
developments and financial prospects in biotechnology from top
executives. Each will give a 20-25 minute presentation followed by
15 minutes of Q&A.
The blue ribbon group of presenters include Daniel Kisner, M.D.,
President of Isis Pharmaceuticals (NASDAQ:ISIP); Steve Engle,
Chairman/CEO of La Jolla Pharmaceutical Co. (NASDAQ:LJPC); Arthur
Benvenuto, Chairman/CEO of Advanced Tissue Sciences (NASDAQ:ATIS);
and Larry Stambaugh, Chairman/CEO, of Maxim Pharmaceuticals
(ASE:MMP).
The San Diego event is the second biotech Forum sponsored by
Informed Investors Forum in recent weeks. On July 27, Informed
Investors hosted a Mid-Year Biotech Forum in Emeryville, CA. David
Crossen, Senior Biotech Analyst with Montgomery Securities, was the
featured speaker.
Companies presenting on July 27 were Chiron Corp. (NASDAQ:CHIR),
Matrix Pharmaceutical (NASDAQ:MATX), Arris Pharmaceuticals
(NASDAQ:ARRS) and Connetics Corp. (NASDAQ:CNCT).
Since 1993, Informed Investors Forums have been linking investors
with management of public companies. Tapes of each Forum are
available for $25. Tape sets for both Biotech Forums is $45. Call
800/992-4683 to register for the Aug. 9 Forum or to order tapes.
CONTACT: Informed Investors
Tim Quast/Bob Taylor/Steve Chanecka, 916/448-8222
or 800/992-4683
KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: BIOTECHNOLOGY TRADESHOW
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
Copyright 1997, Business Wire |
